PharmaBoardroom

András Szabó – CEO, Szinapszis Hungary

Dr. András Szabó, CEO of Szinapszis, a Hungarian market research and consulting agency specialized in the health industry, offers his expert…

A New Approach to Rare Diseases in Canada

Pamela Fralick of Innovative Medicines Canada (IMC) advocates for a collaborative multi-stakeholder approach to better tackle rare diseases in Canada.…

A New Industrial Strategy for Europe: Win-Win for Both Economies…

The EFPIA's Nathalie Moll outlines the case for a new EU-wide industrial strategy with biopharmaceuticals at its heart. The…

Chinese Oncology Biotechs to Watch

Cancer is one of the world’s leading causes of death and in China, the globe’s most populous country, it is an ever-increasing concern. In 2018,…

Hungary’s First Steps into Digital Healthcare

After years of planning and collaboration with various stakeholders, in 2017 the Hungarian government launched the Electronic Health Service Area…

Abu Dhabi’s New Genome Program: Betting on Tailored Health

As part of its endeavour to provide world-class healthcare, on December 10 2019, the Abu Dhabi Department of Health (DoH) announced a national program…

Anna Wienner – General Manager, IBSA Hungary

Anna Wienner, general manager of IBSA Hungary, gives an update on the recent activities and achievement of the affiliate since her previous interview…

Josef Kredba – Country Manager, G.L. Pharma Czech Republic

Josef Kredba, country manager Czech Republic at G.L. Pharma, an Austrian pharmaceutical company, explains how the company has returned to growth in…

Norbert Langen – Founder & CEO, Phytotec, Hungary

Norbert Langen, founder and CEO of Phytotec, a Hungarian distributor of evidence-based natural Rx and OTC drugs, introduces the company and its unique…